These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2892556)

  • 1. Independent regulation of beta 1- and beta 2-adrenoceptors.
    Beer M; Hacker S; Poat J; Stahl SM
    Br J Pharmacol; 1987 Dec; 92(4):827-34. PubMed ID: 2892556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain.
    Beer M; Richardson A; Poat J; Iversen LL; Stahl SM
    Biochem Pharmacol; 1988 Mar; 37(6):1145-51. PubMed ID: 2895652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.
    O'Donnell JM
    J Pharmacol Exp Ther; 1990 Jul; 254(1):147-57. PubMed ID: 1973194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prenalterol on beta adrenergic responsiveness and receptors in the cerebral cortex of the rat.
    Ordway GA; Frazer A
    Neuropharmacology; 1988 May; 27(5):529-36. PubMed ID: 2839793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol.
    Ordway GA; Gambarana C; Frazer A
    J Pharmacol Exp Ther; 1988 Oct; 247(1):379-89. PubMed ID: 2845059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Brain Res Bull; 1996; 41(2):93-6. PubMed ID: 8879672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
    Ordway GA; O'Donnell JM; Frazer A
    J Pharmacol Exp Ther; 1987 Apr; 241(1):187-95. PubMed ID: 3033200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
    Gurden JM; Apperley GH; Drew GM
    J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine.
    Finnegan KT; Terwilliger MM; Berger PA; Hollister LE; Csernansky JG
    Eur J Pharmacol; 1987 Feb; 134(2):131-6. PubMed ID: 3032650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
    Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
    Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sino-aortic denervation causes right atrial beta adrenoceptor down-regulation.
    Zanesco A; Spadari-Bratfisch RC; Barker LA
    J Pharmacol Exp Ther; 1997 Feb; 280(2):677-85. PubMed ID: 9023279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum.
    Paetsch PR; Greenshaw AJ
    Mol Chem Neuropathol; 1993 Sep; 20(1):21-31. PubMed ID: 7902719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
    Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
    J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and molecular characterisation of beta-adrenoceptors in adult rat diaphragm muscle.
    Collet F; Féve B; Frisdal E; Pavoine C; Pecker F; Atlan G
    Respir Physiol; 1998 Apr; 112(1):1-12. PubMed ID: 9696278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clenbuterol and prenalterol on performance during differential reinforcement of low response rate in the rat.
    O'Donnell JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):68-75. PubMed ID: 3572797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex.
    Heal DJ; Butler SA; Hurst EM; Buckett WR
    J Neurochem; 1989 Oct; 53(4):1019-25. PubMed ID: 2549191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E; Mian MA; Raper C
    Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.